$EIGR Eiger BioPharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eiger BioPharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eiger BioPharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Eiger BioPharmaceuticals, Inc. for free.
IRS Number: 361004130
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: EIGR
Company Address: 2155 PARK BOULEVARD PALO ALTO 94306
Phone number: 650-272-6138
Former name: Celladon Corp, date of change: 2004-10-05
Market Capitalization: $93.59M
Prev close: $11.60
Average Daily Volume: 16,595
Days Low: $11.05
Year Low: $10.71
Year High: $23.10
Eiger BioPharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Option Exercise | A | 8.49 | 87,000 | 738,630 | 87,000 | |
| Apr 23 2021 | EIGR | Eiger BioPharmaceu ... | Sablich Kim | Director | Option Exercise | A | 8.43 | 25,000 | 210,750 | 25,000 | |
| Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.50 | 1,000 | 8,500 | 37,500 | 36.5 K to 37.5 K (+2.74 %) |
| Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.48 | 1,500 | 12,720 | 36,500 | 35 K to 36.5 K (+4.29 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 0.00 | 11,875 | 0 | 29,296 | 17.4 K to 29.3 K (+68.16 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Option Exercise | A | 9.99 | 97,500 | 974,025 | 97,500 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Grant | A | 0.00 | 16,250 | 0 | 18,152 | 1.9 K to 18.2 K (+854.36 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Patton Stephana Eilene | See Remarks | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Patton Stephana Eilene | See Remarks | Grant | A | 0.00 | 11,875 | 0 | 17,948 | 6.1 K to 17.9 K (+195.54 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Murray Christine | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Murray Christine | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 |
View all Eiger BioPharmaceuticals, Inc. insider transactions.